APOE and atherosclerosis: The potential immunogenic role of CRAMP in atherosclerosis in the context of MHC-I/self-peptide T cell reactivity was tested first in vitro by 24h or 48h stimulation of splenocytes harvested from 13 week old naïve ApoE(-/-) mice fed normal (NC) using tCRAMP.